Gateway Investment Advisers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CIM
RP
PFSRSONJ
JIC
IHL
CPCPP
P
Gateway Investment Advisers's CRL Position: Q2 2026 in Review
Gateway Investment Advisers increased its Charles River Laboratories (CRL) stake by 13% in Q2 2026, buying an estimated $83K and bringing the position to 3,998 shares worth $907K. The position accounts for 0.01% of the portfolio, ranked #456.
Gateway Investment Advisers first reported a position in CRL in Q2 2018 and has held it in 28 quarters since. 93 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Gateway Investment Advisers held 3,998 shares of Charles River Laboratories worth $907K as of Q2 2026.
- Gateway Investment Advisers bought 466 Charles River Laboratories shares in Q2 2026, an estimated $83K.
- Charles River Laboratories made up 0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #456 holding.
- Gateway Investment Advisers first reported a position in Charles River Laboratories in Q2 2018 and has held it in 28 quarters since.
- 93 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.